The reconstitution decision is permanent once made
The distribution of values was tested by the one-sample KS test, and data are presented as the mean +/ SD or as median and IQR, where appropriate
Syringe Units = Volume to Draw (mL) 100 = 0.1 mL 100 = 10 units GHK-Cu Dosing Profile (50 mg Vial / 2.5 mL BAC Water) 1 mg Dose: Draw 5 units (0.05 mL)
Pricing for compounded combination preparations at Moonshot Medical in Park Ridge, IL is determined during consultation based on the specific patient-specific preparation prescribed
Retatrutide is an investigational triple-hormone receptor agonist developed by Eli Lilly that targets three receptors: GIP (glucose-dependent insulinotropic polypeptide), GLP-1 (glucagon-like peptide-1), and glucagon
Factors affecting individual response include baseline tissue health, severity of issues being addressed, consistency of use, lifestyle factors, current medications, and genetic variables